Clinical Trials

51 enrolled

Stomach Neoplasms

NCT07416552 2026-03-16

A Study to Investigate CEA-PRIT 2.0 in Participants With Metastatic Colorectal Cancer (mCRC)

180 enrolled

Colorectal Neoplasms

NCT07419841 2026-03-16

A Phase 1 Study of the Safety and Tolerability of CTX-10726

GastrointestinalGenitourinaryGynecologic

70 enrolled

Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Endometrial Neoplasms

NCT07391670 2026-03-12

IMFINZI-subQ

40 enrolled

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Hepatocellular, Small Cell Lung Carcinoma

NCT07436988 2026-03-12

ReLIVE

Carcinoma, Hepatocellular, Liver Neoplasms

NCT07453875 2026-03-06

TRIUNITE06

9 enrolled

Colorectal Neoplasms

NCT05038098 2026-03-05

Magnetic Sentinel Lymph Node Mapping in Gastric Cancer

Gastric Adenocarcinoma

NCT07417488 2026-02-27

GUCY2C Prime-Boost Vaccination for Advanced Colorectal and Small Bowel Adenocarcinomas

Colorectal Neoplasms

NCT07272642 2026-02-25

DUNP19

BreastGastrointestinalHead & NeckThoracic

16 enrolled

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms, Triple Negative Breast Neoplasms

NCT07430202 2026-02-24

A DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Glutamine Antagonist DRP-104, Nivolumab, and Ipilimumab in Patients With Advanced Stage Fibrolamellar Carcinoma (FLC)

27 enrolled

Fibrolamellar hepatocellular carcinoma, Carcinoma, Liver Neoplasms

NCT07117032 2026-02-19

Simulation-Free Celiac Plexus Pain Ablation Using Stereotactic Body Radiotherapy (SBRT) in Participants With Cancer-Related Celiac Pain

5 enrolled

Pancreatic Neoplasms, Abdominal Pain

NCT07411781 2026-02-17

PIN in Combination With Sintilimab in Previously Treated pMMR/MSS CRC With Hepatic Metastases

25 enrolled

Colorectal Neoplasms

NCT07409805 2026-02-13

YMN-136 Vaccine for Patients With Liver Metastasis of Colorectal Cancer Progressing After Third-Line Treatment

9 enrolled

Colorectal Neoplasms

NCT06203821 2026-02-05

Study of Perioperative NP137 and FOLFIRINOX in Resectable Pancreatic Cancer

25 enrolled

Pancreatic Neoplasms

NCT06217666 2026-02-05

Study Examining the Safety and Toxicity of Stereotactic Body Radiotherapy (SBRT) Followed by PCX12 Immunotherapy Delivered by Intratumoral Injection for the Treatment of Patients With Locally Advanced Pancreatic Adenocarcinoma (LAPC)

24 enrolled

Pancreatic Neoplasms

NCT07107750 2026-02-04

Emavusertib (CA-4948) in Combination With Cisplatin, Gemcitabine, and Durvalumab in Patients With Untreated Advanced or Metastatic Biliary Tract Cancer

48 enrolled

Biliary Tract Neoplasms

NCT07365839 2026-01-27

CLeAR

Carcinoma, Hepatocellular

NCT07363408 2026-01-23

Ivonescimab and ADG126, Alone, and in Combination With Leucovorin and Fluorouracil or FOLFIRI Regimen for the Treatment of Microsatellite Stable Advanced/Metastatic Colorectal Cancer

30 enrolled

Colorectal Neoplasms

NCT07358884 2026-01-22

First in Human Study of QLS5316 in Solid Tumors

GastrointestinalHead & NeckThoracic

300 enrolled

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Stomach Neoplasms, Colorectal Neoplasms

NCT07333820 2026-01-12

Clinical Study to Evaluate the Safety and Anti-Tumor Activity of AB-201

Stomach Neoplasms

NCT06283134 2026-01-07

A Clinical Study of BioTTT001 in Combination With Toripalimab and Regorafenib in Patients With Colorectal Cancer

60 enrolled

Colorectal Neoplasms

NCT07314385 2026-01-02

NH002-mediated Sonoporation With Chemotherapy in Advanced Pancreatic Cancer

24 enrolled

Pancreatic Adenocarcinoma Metastatic

NCT07252661 2025-11-28

Study of ACC-1898 in Adult Participants With Advanced Solid Tumors

DermatologicEndocrineGastrointestinalGenitourinaryHead & Neck

40 enrolled

Thyroid cancer, medullary, Carcinoma, Renal Cell, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Melanoma, Neoplasm Metastasis

NCT07196384 2025-11-21

GLOW

15 enrolled

Esophageal Neoplasms

NCT07075120 2025-10-28

Ipilimumab and Nivolumab With SBRT in Locally Advanced Hepatocellular Cancer

15 enrolled

Carcinoma, Hepatocellular

NCT07203898 2025-10-02

A Study of IPM514 in Patients With Esophageal Squamous Cell Carcinoma.

36 enrolled

Esophageal Squamous Cell Carcinoma

NCT07173374 2025-09-15

SCART-P

24 enrolled

Pancreatic Neoplasms

NCT07171203 2025-09-12

Neoadjuvant Imatinib and Fampridine in KIT Mutant Gastrointestinal Stromal Tumor

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT07165132 2025-09-10

Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.

EndocrineGastrointestinalNET

104 enrolled

Gastro-enteropancreatic neuroendocrine tumor, Carcinoid Tumor, Adenoma, Islet Cell, Neuroendocrine Tumors

NCT07077369 2025-07-22

WGc-0201 Plus Tislelizumab in HCC With High Risk of Recurrence and Metastasis After Radical Therapy

10 enrolled

Carcinoma, Hepatocellular

NCT07060014 2025-07-11

NALIRIFOX (Nal-IRI Plus 5-FU/LV Plus Oxaliplatin) as First-Line Treatment for Patients With Advanced Small Intestine and Appendiceal Cancers

22 enrolled

Advanced Small Intestine Cancer

NCT07036185 2025-06-25

A Clinical Trail of KJ015 in Patients With HER2-Expressing Solid Tumors

BreastGastrointestinalHead & NeckThoracic

66 enrolled

Squamous Cell Carcinoma of Head and Neck, Bile Duct Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms

NCT07034118 2025-06-24

Definitive Proton Radiotherapy Combined With Chemotherapy and Immunotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Phase I Clinical Study

23 enrolled

Esophageal Neoplasms

NCT07031011 2025-06-22

PD-1-M1-NK Cells in the Treatment of Advanced Gastric or Colorectal Cancer

22 enrolled

Colorectal Neoplasms

NCT07014878 2025-06-11

A Study of DCTY1102 Injection in Patients With Advanced Solid Tumors

110 enrolled

Colorectal Neoplasms

NCT06994572 2025-05-29

Study of CT-01 as Monotherapy and Combination Therapy in Subjects With Intermediate or Advanced Hepatocellular Carcinoma

141 enrolled

Carcinoma, Hepatocellular

NCT06990620 2025-05-25

TACE HCC

56 enrolled

Carcinoma, Hepatocellular

NCT05048368 2025-05-18

Pharmacokinetics Study of Larotinib in Subjects With Impaired Hepatic Function

32 enrolled

Esophageal Neoplasms

NCT06963502 2025-05-09

A Phase Ib Study of HS-10370 in Addition to Other Anti-cancer Therapies in Patients With Advanced Solid Tumors

762 enrolled

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms

NCT06948539 2025-04-29

To Evaluate the Tolerability and Pharmacokinetics of TQB2101 for Injection in Patients With Advanced Malignant Tumors

BreastGastrointestinalThoracic

66 enrolled

Breast Neoplasms, Lung Neoplasms, Colorectal Neoplasms

NCT06935149 2025-04-24

PSMA

5 enrolled

Liver Metastasis Colon Cancer

NCT04062721 2025-04-06

LICoRN-01

12 enrolled

Colorectal Neoplasms

NCT06913218 2025-04-06

A Study of mRNA Vaccines AK154 Monotherapy or in Combination With AK104/AK112,and Sequential mFOLFIRINOX in Surgically Resected PDAC

60 enrolled

Pancreatic Neoplasms

NCT06882915 2025-03-19

Efficacy and Safety of Trifluridine/tipiracil (TAS-102) Combined with Bevacizumab and Putalimab in the Treatment of Patients with MCRC After Cytoreductive Surgery: a Single-arm, Single-center Clinical Study

Colorectal Neoplasms

NCT06822985 2025-02-12

QL1706

21 enrolled

Carcinoma, Hepatocellular

NCT06760676 2025-01-07

A Multiple Tumor Species, Open and Multi-center Clinical Study of Alpaloritovorelli Antibodies (QL-1706) Combined with Pulsed Low Dose Rate External Irradiation (PLDR) for Disease Progression After Previous Anti-tumor Therapy

GastrointestinalGynecologicThoracic

90 enrolled

Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Esophageal Neoplasms

NCT06755242 2025-01-01

A Study of GNC-077 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors and Other Solid Tumors

Digestive System Neoplasms

NCT06652529 2024-11-07

AROG4-01-01

GastrointestinalGynecologicOther solid neoplasmThoracic

35 enrolled

Carcinoma, Non-Small-Cell Lung, Mesothelioma, Ovarian Neoplasms, Colorectal Neoplasms

NCT06614751 2024-09-27

A PARG Inhibitor DAT-2645 Monotherapy in Patients with Advanced/Metastatic Solid Tumors Harboring BRCA1/2 Loss of Function Alterations And/or Other Defects in the DDR Pathway